Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Saved in:
| Title: | Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. |
|---|---|
| Authors: | Matossian MD; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Burks HE; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Elliott S; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Hoang VT; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Bowles AC; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA., Sabol RA; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA., Wahba B; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Anbalagan M; Department of Structural and Cellular Biology, Tulane University, New Orleans, LA, USA., Rowan B; Department of Structural and Cellular Biology, Tulane University, New Orleans, LA, USA., Abazeed ME; Cleveland Clinic, Department of Radiation Oncology, Cleveland, OH, USA., Bunnell BA; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, USA.; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA., Moroz K; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA.; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA., Miele L; Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Rhodes LV; Department of Biology, Florida Gulf Coast University, Fort Myers, FL, USA., Jones SD; Tulane Cancer Center, New Orleans, LA, USA.; Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA., Martin EC; Department of Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Collins-Burow BM; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.; Tulane Cancer Center, New Orleans, LA, USA., Burow ME; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA. mburow@tulane.edu.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, USA. mburow@tulane.edu.; Tulane Cancer Center, New Orleans, LA, USA. mburow@tulane.edu. |
| Source: | BMC cancer [BMC Cancer] 2019 Mar 07; Vol. 19 (1), pp. 205. Date of Electronic Publication: 2019 Mar 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-019-5401-2 |
